DS-7300 Continues to Show Promising Durable Response in Patients with Several Types of Advanced Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced that Sarah.
Initial dose escalation results from first-in-human phase 1 trial of DS-6000, Daiichi Sankyo's fifth DXd ADC in clinical development, featured in oral presentation at ASCO Dose expansion phase
Today, Sarah Cannon Research Institute announced that it will highlight its latest cancer research insights through more than 140 abstracts and presentations at the 2022 American Society of Clinical